Survival after liver transplantation using hepatitis C virus-positive donor allografts: Case-controlled analysis of the UNOS database

World Journal of Surgery

Volumn 35, Issue 7, 2011, Pages 1590-1595

  Burr, Andrew T ^a   Li, Youfu ^a   Tseng, Jennifer F ^a   Saidi, Reza F ^a   Bozorgzadeh, Adel ^a   Shah, Shimul A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DONOR; FACTUAL DATABASE; FEMALE; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS;

EID: 80051552709     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1019-5     Document Type: Conference Paper

References (12)

1. United Network for Organ Sharing (2009) Transplant patient data source. Available at http://www.patients.unos.org/data.htm. Accessed 19 Aug 2009
2. B Pereira E Milford R Kirkman 1992 Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients N Engl J Med 327 910 915 1325035 10.1056/NEJM199209243271302 1:STN:280:DyaK38zot1Kisg%3D%3D
3. B Dominguez-Gil JM Morales 2009 Transplantation in the patient with hepatitis C Transplant Int 22 1117 1131 10.1111/j.1432-2277.2009.00926.x 1:CAS:528:DC%2BD1MXhsFOmtbjM
4. D Rubin 1997 Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 757 763 9382394 1:STN:280: DyaK2svmvVKitQ%3D%3D (Pubitemid 27446562)
5. P Austin P Grootendorst SL Normand, et al. 2007 Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study Stat Med 26 754 768 16783757 10.1002/sim.2618 (Pubitemid 46206594)
6. AP Khapra K Agarwal MI Fiel, et al. 2006 Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts Liver Transpl 12 1496 1503 16964597 10.1002/lt.20849 (Pubitemid 44594280)
7. RM Ghobrial R Seadman J Gornbein, et al. 2001 A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients Ann Surg 234 384 394 11524591 10.1097/00000658-200109000- 00012 1:STN:280:DC%2BD3MvotVyltg%3D%3D (Pubitemid 32847075)
8. NA Terrault ML Shiffman AS Lok, et al. 2007 Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation Liver Transpl 13 122 129 17192908 10.1002/lt.20995 (Pubitemid 46099981)
9. HE Vargas T Laskus LF Wang, et al. 1999 Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts Gastroenterology 117 149 153 10381921 10.1016/S0016-5085(99)70561-5 1:STN:280:DyaK1MzhsFGlsA%3D%3D (Pubitemid 29297631)
10. G Testa V Vidanovic G Chejfec, et al. 2008 Adult living-donor liver transplantation with ABO-incompatible grafts Transplantation 85 681 686 18337660 10.1097/TP.0b013e3181665172 (Pubitemid 351398243)
11. E Velidedeoglu NM Desai L Campos, et al. 2002 The outcome of liver grafts procured from hepatitis C-positive donors Transplantation 73 582 587 11889435 10.1097/00007890-200202270-00018 (Pubitemid 34193620)
12. D Axelrod M Schnitzler PR Salvalaggio, et al. 2007 The economic impact of the utilization of liver allografts with high donor risk index Am J Transpl 7 990 997 10.1111/j.1600-6143.2006.01724.x 1:STN:280:DC%2BD2s7ptVamsA%3D%3D (Pubitemid 46481202)